Stay updated on Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior operating-status notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:55:35.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding affecting updates and the NIH Clinical Center's status. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:28:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new 'Show glossary' toggle is added, along with footer metadata showing 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The deletions remove older wording/variants ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4'), reflecting a minor UI update and data-label cleanup. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:08:10.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; no study details, enrollment, or eligibility information appear to be changed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:25:21.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A Locations section with a Washington entry has been added, improving visibility of where the study is conducted. The previous 'Washington Locations' entry and the HHS Vulnerability Disclosure have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:14:57.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publications description updated to indicate that items are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:06:12.000Z thumbnail image

Stay in the know with updates to Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.